To investigate the potential contribution of the lysosomal compartment in the processing of amyloid precursor protein (APP) to amyloid ,8-peptides (A,fs), we stably overexpressed a series of lysosomal proteases (the cysteine proteases, cathepsins B, L and S, and the aspartic protease, cathepsin D) in a human kidney epithelial cell line (293) Aft secretion by the cathepsin S transfectants, but had no effect INTRODUCTION
INTRODUCTION
Alzheimer's disease (AD) is characterized by the presence of the 4 kDa amyloid f-peptide (Aft) within plaques and vascular deposits ofaffected brains. Aft is derived by proteolytic processing of an integral membrane protein, ft-amyloid precursor protein (ftAPP) [1] , which is encoded by a gene on chromosome 21 and can exist in four major isoforms determined by alternative mRNA splicing (/JAPP 563, 695, 751 and 770) [1] [2] [3] [4] [5] . After posttranslational processing in the endoplasmic reticulum and Golgi, ,fAPP can undergo proteolysis within the A,f domain by an enzyme termed a-secretase to generate a soluble form of ftAPP (APPS) [6, 7] and an 10 kDa membrane-associated C-terminal fragment [8] . Alternatively, ftAPP, which contains a potential internalization sequence in its C-terminal cytoplasmic tail [9] , can be re-internalized from the cell surface and degraded in the endosomal-lysosomal system, where multiple C-terminal fragments, some of which contain the entire Aft region, can be detected in cultured cells and human cerebral cortex [10] [11] [12] .
Although controversy exists as to whether A,f is a direct cause of AD, there is ample circumstantial evidence implicating ftAPP and A,8 in its pathogenesis, including the finding of early AD neuropathology in trisomy 21, in which the gene dosage and expression of ftAPP are increased, and several mutations of the ,fAPP gene that result in early-onset, familial forms of AD [13] [14] [15] [16] . Soluble A,f is constitutively secreted by a number of cell types [17] [18] [19] , and recent evidence implicates the endosomal compartment as a site of A,f generation [20] . A related protein, p3, is also secreted; it is a C-terminal fragment of terminus at or adjacent to the a-secretase site. Numerous enzymes present in mammalian brain have been shown in experiments in vitro to have potential Aft N-terminal cleaving ability, including multicatalytic protease [21] , clipsin [22] , a calcium-activated cathepsin G-like seine protease [23] , metalloendopeptidase 24.15 [24] and cathepsin D [25] . Cathepsin G also has this activity [26] but is not detectable in human brain [27] . None [8, 29] . Cathepsin S cDNA in pcDNA-I (Invitrogen) [28] 10 min, then added to complete medium (DMEM containing 10 % fetal-calf serum, penicillin, streptomycin and 800 ,ug/ml G418). After 48 h, the medium was changed and hygromycin B added at 100 ,ug/ml. Cysteine protease transfectants were analysed -2 weeks after transfection by active-site radiolabelling with 125I-JPM-565 (an iodinated analogue of E-64), followed by SDS/PAGE and autoradiography, as described previously [28] [17] . Immunoblotting of cell lysates using the antibody designated aC7 [8, 32] , which recognizes amino acids 676-695 of ,/APP [1] , was as described [33] , after overnight incubation with E-64d or diluent. ELISA of Afl in conditioned medium was as described [18] ; transfected 293 cells were placed in 35-mm-diam. wells, cultured to confluence, then washed with DMEM followed by addition of fresh medium containing E-64d (10 l,M final concentration, from 10 mM stock in dimethyl sulphoxide) or diluent. Media were collected after 24 h and assayed in blind fashion. Cells were then detached by treatment with trypsin and EDTA and counted. Statistical significance was determined by 
Anti-cathepsin S antibody
A cathepsin S-maltose binding protein (MBP) fusion protein was used to immunize rabbits as described previously [34] . The resulting antiserum recognizes a single 28 kDa band in our gel system that co-migrates with cathepsin S (as detected by activesite radiolabelling) in immunoblots of lysates of human alveolar macrophages and cathepsin S-transfected 293 cells, but not in immunoblots of lysates of untransfected 293 cells. Antiserum was purified by adsorption to cathepsin S-MBP blotted to nitrocellulose after separation by SDS/PAGE, followed by elution at low pH, as described in [35] . Specificity of the resulting antibody preparation was determined by adsorbing the purified antibody with cathepsin S-MBP or cathepsin L-MBP [34] blotted on to nitrocellulose, followed by immunoblotting of cell lysates containing cathepsin S as above; adsorption to cathepsin S, but not cathepsin L, abrogated the ability of the purified antibody to recognize cathepsin S. 20 clones expressed cathepsin B at levels moderately above control, and one of these was selected for study ( [36] [37] [38] ; note that cathepsin S is not detectable except with cathepsin S transfection. The fully processed single-chain (30 kDa) and two-chain (25 and 5 kDa) forms of cathepsin L do not incorporate label, as previously reported [37] . Overexpression of cathepsins B and S results in a loss of procathepsin L ( Figure Ia, lanes 1-3) , suggesting that cathepsins B and S, in addition to cathepsin L itself [39] , process cathepsin L precursors. Labelled cathepsin S migrates at 28 kDa, as described previously [28] , rather than at 24 kDa as reported by others [40] ; its identity was confirmed by immunoblotting and co-migration of active-site-labelled human cathepsin S and purified bovine cathepsin S in our gels (results not shown).
Cathepsin D transfection was confirmed by immunoblotting of cell lysates, shown in Figure l(b) . Immature forms of 51, 44 and 34 kDa, and the mature 31 kDa form [41] , are increased in (Figure 2) . Overexpression, or inhibition, of the various cysteine proteases had no significant effect on the level of p3 release (Figure 2 ). Conditioned media were collected from the same cells and assayed for A,l by ELISA [18] . Only cathepsin S expression resulted in an increase in A/I secretion above control levels, and this increase was largely inhibited by E-64d ( cell lines, E-64d causes an increase in the -10 kDa fragment resulting from a-secretase action, analogous to previous results using leupeptin [17] and suggesting that lysosomal cysteine 
Radiosequencing of Afl peptides
To determine the N-termini of AA peptides released by cells expressing 8APP 695 and cathepsin S, radiosequencing of immunoprecipitated Aft was done. Radiosequencing of the [3H]phenylalanine-labelled, immunoprecipitated AAt ( Figure 4 ) revealed a 3H peak at cycle 4, consistent with the previously described predominant AAt N-terminus Asp 1 [17] , and also a peak at cycle 5 consistent with an Af species starting at Met -1.
In the experiment shown in Figure 4 , the Met -1 species is calculated to be 45 % of the total Aft. In two additional experiments, the Met -peptide represented 27 % and 37 % of the total AA (results not shown), resulting in a mean value of 360% (S.D., 9 %). It should be noted that these calculations assume no spillover of 3H from cycle 4 into cycle 5. To the extent that some spillover does occur, then the calculated fractions of Met -1 peptide to the total Aft could be overestimated. To confirm the existence of a Met -1 N-terminus, we radiosequenced [35S]methionine-labelled Af from the same cells incubated in the presence or absence of E-64d. The peak obtained at cycle I (Figure 4) indicates a Met -1 N-terminus, and disappears after treatment with E-64d as expected. Figure 5 (c). Staining was markedly attenuated by adsorption of affinity-purified antibody to cathepsin S fusion protein (Figure 5d) [28, [48] [49] [50] [51] , for several reasons. First, cathepsin S is not normally produced by the cell line studied here, so that expression by transfection allows a direct assessment of its effect. Secondly, cathepsin S, which prefers substrates with small hydrophobic residues in the P2 and P3 positions [40] and can cleave highly hydrophobic insoluble elastin [28] , might be capable of proteolysis of APP in the hydrophobic region near the Aft C-terminus. Thirdly, cathepsin S has significant activity at neutral pH (unlike other lysosomal cysteine proteases), suggesting that it could be active in less acidic compartments of the cell (e.g. early endosomes) where A,f generation might occur [20] . Finally, cathepsin S appears to be a regulated and inducible gene product (in contrast to ubiquitous lysosomal proteases such as cathepsins B, L and D) [34] that has been detected in adult rat brain [48, 52] [40] . Cathepsin L, which most closely resembles cathepsin S in sequence and substrate specificity [28, 52] , has been reported to cleave a synthetic analogue of the Aft N-terminus at the Lys -2/Met -1 bond [56] .
We also investigated the effect of cathepsin S transfection on 293 cells overexpressing a /3APP mutant (Val 642 -+ Ile) [29] associated with early-onset, familial AD. We reasoned that an alteration in amino acid sequence at the A,t N-terminus might enhance its degradation by cathepsin S. However, the increase in A,f secretion that we observed in such doubly transfected cells was also -2-fold (results not shown).
This is the first description of a means to increase A,8 secretion in cells expressing equal amounts of ftAPP. Although the observed increase is modest, the facts that a ftAPP mutation associated with early-onset, familial AD results in a 5-8-fold increase in Aft secretion in transfected cells [57, 58] , and that trisomy 21 (in which there is a 500% increase in ftAPP gene dosage) is associated with early AD pathology, suggest that changes in A,f secretion of the magnitude produced by cathepsin S could be relevant to increased Aft accumulation in the brain.
The Met -1 form of Aft has not been detected in clinical samples of AD brain; thus, if the cathepsin S pathway described here is operative in vivo, there must be additional proteolytic processing of the Met -1 form.
The extent of expression of cathepsin S in normal and diseased human brain has not previously been investigated. Cathepsin S mRNA is expressed in rat brain, probably predominantly in microglia [45, 52] , consistent with its expression in human monocytes and lung macrophages [28, 34] . Northern blotting of normal human brain RNA, however, does not reveal detectable cathepsin S [34] . We used an affinity-purified polyclonal antibody to cathepsin S to examine cathepsin S expression in human brain. This antibody preparation recognizes cathepsin S, but not cathepsins B, L or H, on immunoblots of lysates of human alveolar macrophages, and demonstrates cathepsin S expression in lung macrophages by immunostaining techniques essentially identical to those used here [34] . Also, the antibody confirms expression of cathepsin S in transfected 293 cells in a pattern consistent with a lysosomal distribution ( Figure 5 ). As expected, there was little or no detectable cathepsin S in normal brain. In contrast, focal cellular immunostaining of cortical neurons and glial cells was found in AD brain ( Figure 5 ). Although glial expression is not unexpected, the prominent neuronal immunostaining is unanticipated. These data do not establish sites of cathepsin S synthesis, and it is possible that neurons have internalized cathepsin S produced by other cells. An extensive immunohistochemical analysis of cathepsin S expression in AD and other disease states will be published separately [59] . In summary, our data indicate that an alternative, lysosomal pathway of Aft production can exist in cells expressing cathepsin (e.g., Val -3, Ile -6, Arg 6 and Glu 11) [17, 18, 54, 55] . There is S. Because cathepsin S has characteristics of an inducible gene (e.g. multiple predicted AP-l binding sites and a consensus heat shock element sequence at -168 to -145 bp, [34] ) and appears to be up-regulated in AD brain ( Figure 5 ), we propose that this is an inducible lysosomal pathway that may play a role in the course of /J-amyloidosis in AD.
